IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,221,447 | +109495.5% | 3,510,173 | -0.9% | 8.52% | +11.7% |
| Q2 2023 | $145,281 | +14.8% | 3,540,858 | -0.0% | 7.63% | +10.7% |
| Q1 2023 | $126,557 | -5.4% | 3,541,046 | -0.0% | 6.89% | -3.3% |
| Q4 2022 | $133,749 | -99.9% | 3,541,136 | +30.0% | 7.12% | +34.4% |
| Q3 2022 | $120,438,000 | +19.3% | 2,722,988 | -0.1% | 5.30% | +28.4% |
| Q2 2022 | $100,945,000 | -6.8% | 2,726,778 | -6.8% | 4.13% | +17.9% |
| Q1 2022 | $108,346,000 | – | 2,925,102 | – | 3.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |